Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

Similar articles for PubMed (Select 22561517)

1.

Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma.

Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, Calderaro J, Bioulac-Sage P, Letexier M, Degos F, Clément B, Balabaud C, Chevet E, Laurent A, Couchy G, Letouzé E, Calvo F, Zucman-Rossi J.

Nat Genet. 2012 May 6;44(6):694-8. doi: 10.1038/ng.2256.

2.

Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma.

Gu DL, Chen YH, Shih JH, Lin CH, Jou YS, Chen CF.

World J Gastroenterol. 2013 Dec 21;19(47):8873-9. doi: 10.3748/wjg.v19.i47.8873. Review.

3.

Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification.

Ahn SM, Jang SJ, Shim JH, Kim D, Hong SM, Sung CO, Baek D, Haq F, Ansari AA, Lee SY, Chun SM, Choi S, Choi HJ, Kim J, Kim S, Hwang S, Lee YJ, Lee JE, Jung WR, Jang HY, Yang E, Sung WK, Lee NP, Mao M, Lee C, Zucman-Rossi J, Yu E, Lee HC, Kong G.

Hepatology. 2014 Dec;60(6):1972-82. doi: 10.1002/hep.27198. Epub 2014 Sep 22.

PMID:
24798001
4.

Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma.

Kim YD, Park CH, Kim HS, Choi SK, Rew JS, Kim DY, Koh YS, Jeung KW, Lee KH, Lee JS, Juhng SW, Lee JH.

J Gastroenterol Hepatol. 2008 Jan;23(1):110-8. doi: 10.1111/j.1440-1746.2007.05250.x.

PMID:
18171349
5.

Paediatric hepatocellular carcinoma due to somatic CTNNB1 and NFE2L2 mutations in the setting of inherited bi-allelic ABCB11 mutations.

Vilarinho S, Erson-Omay EZ, Harmanci AS, Morotti R, Carrion-Grant G, Baranoski J, Knisely AS, Ekong U, Emre S, Yasuno K, Bilguvar K, Günel M.

J Hepatol. 2014 Nov;61(5):1178-83. doi: 10.1016/j.jhep.2014.07.003. Epub 2014 Jul 10.

PMID:
25016225
6.

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.

Boyault S, Rickman DS, de Reyniès A, Balabaud C, Rebouissou S, Jeannot E, Hérault A, Saric J, Belghiti J, Franco D, Bioulac-Sage P, Laurent-Puig P, Zucman-Rossi J.

Hepatology. 2007 Jan;45(1):42-52.

PMID:
17187432
7.

The genomic landscape of hepatoblastoma and their progenies with HCC-like features.

Eichenmüller M, Trippel F, Kreuder M, Beck A, Schwarzmayr T, Häberle B, Cairo S, Leuschner I, von Schweinitz D, Strom TM, Kappler R.

J Hepatol. 2014 Dec;61(6):1312-20. doi: 10.1016/j.jhep.2014.08.009. Epub 2014 Aug 15.

PMID:
25135868
8.

Diverse modes of genomic alteration in hepatocellular carcinoma.

Jhunjhunwala S, Jiang Z, Stawiski EW, Gnad F, Liu J, Mayba O, Du P, Diao J, Johnson S, Wong KF, Gao Z, Li Y, Wu TD, Kapadia SB, Modrusan Z, French DM, Luk JM, Seshagiri S, Zhang Z.

Genome Biol. 2014 Aug 26;15(8):436. doi: 10.1186/s13059-014-0436-9.

10.

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.

Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, Zucman-Rossi J.

Hepatology. 2008 Jun;47(6):1955-63. doi: 10.1002/hep.22256.

PMID:
18433021
11.

Integrated analysis of mutation data from various sources identifies key genes and signaling pathways in hepatocellular carcinoma.

Zhang Y, Qiu Z, Wei L, Tang R, Lian B, Zhao Y, He X, Xie L.

PLoS One. 2014 Jul 2;9(7):e100854. doi: 10.1371/journal.pone.0100854. eCollection 2014.

12.

Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.

Wang K, Lim HY, Shi S, Lee J, Deng S, Xie T, Zhu Z, Wang Y, Pocalyko D, Yang WJ, Rejto PA, Mao M, Park CK, Xu J.

Hepatology. 2013 Aug;58(2):706-17. doi: 10.1002/hep.26402. Epub 2013 Jul 1.

PMID:
23505090
13.

AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.

Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y.

Nat Genet. 2000 Mar;24(3):245-50.

PMID:
10700176
14.

Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.

Endo M, Yasui K, Zen Y, Gen Y, Zen K, Tsuji K, Dohi O, Mitsuyoshi H, Tanaka S, Taniwaki M, Nakanuma Y, Arii S, Yoshikawa T.

Liver Int. 2013 Jan;33(1):105-17. doi: 10.1111/liv.12005. Epub 2012 Oct 22.

PMID:
23088494
15.

TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.

Hussain SP, Schwank J, Staib F, Wang XW, Harris CC.

Oncogene. 2007 Apr 2;26(15):2166-76. Review.

PMID:
17401425
16.

Somatic changes in primary liver cancer in Russia: a pilot study.

Kalinina O, Marchio A, Urbanskii AI, Tarkova AB, Rebbani K, Granov DA, Dejean A, Generalov MI, Pineau P.

Mutat Res. 2013 Aug 15;755(2):90-9. doi: 10.1016/j.mrgentox.2013.06.019. Epub 2013 Jul 2.

PMID:
23830926
17.

Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma.

Kan Z, Zheng H, Liu X, Li S, Barber TD, Gong Z, Gao H, Hao K, Willard MD, Xu J, Hauptschein R, Rejto PA, Fernandez J, Wang G, Zhang Q, Wang B, Chen R, Wang J, Lee NP, Zhou W, Lin Z, Peng Z, Yi K, Chen S, Li L, Fan X, Yang J, Ye R, Ju J, Wang K, Estrella H, Deng S, Wei P, Qiu M, Wulur IH, Liu J, Ehsani ME, Zhang C, Loboda A, Sung WK, Aggarwal A, Poon RT, Fan ST, Wang J, Hardwick J, Reinhard C, Dai H, Li Y, Luk JM, Mao M.

Genome Res. 2013 Sep;23(9):1422-33. doi: 10.1101/gr.154492.113. Epub 2013 Jun 20.

18.
19.

Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.

Li S, Mao M.

Cancer Lett. 2013 Nov 1;340(2):247-53. doi: 10.1016/j.canlet.2012.09.027. Epub 2012 Oct 12. Review.

PMID:
23063663
20.

Early molecular and genetic determinants of primary liver malignancy.

Feitelson MA, Pan J, Lian Z.

Surg Clin North Am. 2004 Apr;84(2):339-54. Review.

PMID:
15062649
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk